{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:12:24Z","timestamp":1781136744650,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T00:00:00Z","timestamp":1394755200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s40291-014-0095-2","type":"journal-article","created":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T22:08:29Z","timestamp":1394748509000},"page":"445-450","source":"Crossref","is-referenced-by-count":21,"title":["CYP1A1 Ile462Val Polymorphism as a Risk Factor in Cervical Cancer Development in the Polish Population"],"prefix":"10.1007","volume":"18","author":[{"given":"Andrzej","family":"Roszak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Lianeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sowi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel P.","family":"Jagodzi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,14]]},"reference":[{"issue":"8","key":"95_CR1","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","volume":"19","author":"A Jemal","year":"2010","unstructured":"Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893\u2013907.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"95_CR2","first-page":"391","volume":"14","author":"S Georgieva","year":"2009","unstructured":"Georgieva S, Iordanov V, Sergieva S. Nature of cervical cancer and other HPV-associated cancers. J BUON. 2009;14(3):391\u20138.","journal-title":"J BUON"},{"issue":"1","key":"95_CR3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"issue":"6","key":"95_CR4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10156-012-0485-5","volume":"18","author":"T Sasagawa","year":"2012","unstructured":"Sasagawa T, Takagi H, Makinoda S. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer. J Infect Chemother. 2012;18(6):807\u201315.","journal-title":"J Infect Chemother"},{"key":"95_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477","volume":"31","author":"X Castellsague","year":"2003","unstructured":"Castellsague X, Munoz N. Chapter 3: cofactors in human papillomavirus carcinogenesis\u2014role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003;31:20\u20138.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1612","key":"95_CR6","doi-asserted-by":"crossref","first-page":"20120431","DOI":"10.1098\/rstb.2012.0431","volume":"368","author":"DW Nebert","year":"2013","unstructured":"Nebert DW, Wikvall K, Miller WL. Human cytochromes P450 in health and disease. Philos Trans R Soc Lond B Biol Sci. 2013;368(1612):20120431.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"95_CR7","first-page":"3367","volume":"50","author":"ME McManus","year":"1990","unstructured":"McManus ME, Burgess WM, Veronese ME, et al. Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochrome P-450. Cancer Res. 1990;50:3367\u201376.","journal-title":"Cancer Res"},{"issue":"2","key":"95_CR8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/138920011795016854","volume":"12","author":"K Monostory","year":"2011","unstructured":"Monostory K, Dvorak Z. Steroid regulation of drug-metabolizing cytochromes P450. Curr Drug Metab. 2011;12(2):154\u201372.","journal-title":"Curr Drug Metab"},{"issue":"4","key":"95_CR9","first-page":"720","volume":"48","author":"DD Petersen","year":"1991","unstructured":"Petersen DD, McKinney CE, Ikeya K, et al. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet. 1991;48(4):720\u20135.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"95_CR10","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/IGC.0b013e3181b9fa5d","volume":"19","author":"G Gutman","year":"2009","unstructured":"Gutman G, Morad T, Peleg B, et al. Cyp1a1 and cyp2d6 gene polymorphisms in Israeli Jewish women. Int J Gynecol Cancer. 2009;19(8):1300\u20132.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"95_CR11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ygyno.2005.11.018","volume":"101","author":"C Taskiran","year":"2006","unstructured":"Taskiran C, Aktas D, Yigit-Celik N, et al. CYP1A1 gene polymorphism as a risk factor for cervical intraepithelial neoplasia and invasive cervical cancer. Gynecol Oncol. 2006;101(3):503\u20136.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"95_CR12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ygyno.2005.10.033","volume":"101","author":"T Joseph","year":"2006","unstructured":"Joseph T, Chacko P, Wesley R, et al. Germline genetic polymorphisms of cyp1a1, gstm1 and gstt1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol Oncol. 2006;101(3):411\u20137.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"95_CR13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1525-1438.2003.13607.x","volume":"13","author":"T Sugawara","year":"2003","unstructured":"Sugawara T, Nomura E, Sagawa T, et al. Cyp1a1 polymorphism and risk of gynecological malignancy in Japan. Int J Gynecol Cancer. 2003;13(6):785\u201390.","journal-title":"Int J Gynecol Cancer"},{"key":"95_CR14","doi-asserted-by":"crossref","unstructured":"Liu L, Wu G, Xue F, et al. Functional CYP1A1 genetic variants, alone and in combination with smoking, contribute to development of head and neck cancers. Eur J Cancer. 2013.","DOI":"10.1016\/j.ejca.2013.01.028"},{"issue":"3","key":"95_CR15","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s13277-013-0676-4","volume":"34","author":"G Han","year":"2013","unstructured":"Han G, Ma Y, Liu P, et al. Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk. Tumour Biol. 2013;34(3):1511\u20136.","journal-title":"Tumour Biol"},{"issue":"8","key":"95_CR16","doi-asserted-by":"crossref","first-page":"e43397","DOI":"10.1371\/journal.pone.0043397","volume":"7","author":"YN Ji","year":"2012","unstructured":"Ji YN, Wang Q, Suo LJ. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis. PLoS ONE. 2012;7(8):e43397.","journal-title":"PLoS ONE"},{"issue":"11","key":"95_CR17","doi-asserted-by":"crossref","first-page":"9921","DOI":"10.1007\/s11033-012-1860-0","volume":"39","author":"TN Sergentanis","year":"2012","unstructured":"Sergentanis TN, Economopoulos KP, Choussein S, et al. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis. Mol Biol Rep. 2012;39(11):9921\u201330.","journal-title":"Mol Biol Rep"},{"issue":"6","key":"95_CR18","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s13277-012-0467-3","volume":"33","author":"X Zhuo","year":"2012","unstructured":"Zhuo X, Zhao H, Chang A, et al. Cytochrome P450 1A1 Ile462Val polymorphism and oral carcinoma risk: an updated meta-analysis including 1,515 cases and 2,233 controls. Tumour Biol. 2012;33(6):2079\u201389.","journal-title":"Tumour Biol"},{"issue":"4","key":"95_CR19","first-page":"663","volume":"25","author":"T \u00d6zt\u00fcrk","year":"2011","unstructured":"\u00d6zt\u00fcrk T, Kahraman \u00d6T, Topta\u015f B, et al. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population. In Vivo. 2011;25(4):663\u20138.","journal-title":"In Vivo"},{"issue":"2","key":"95_CR20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3748\/wjg.v17.i2.260","volume":"17","author":"JQ Jin","year":"2011","unstructured":"Jin JQ, Hu YY, Niu YM, et al. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis. World J Gastroenterol. 2011;17(2):260\u20136.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"95_CR21","doi-asserted-by":"crossref","first-page":"e46974","DOI":"10.1371\/journal.pone.0046974","volume":"7","author":"W Zhuo","year":"2012","unstructured":"Zhuo W, Zhang L, Zhu B, et al. Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls. PLoS ONE. 2012;7(10):e46974.","journal-title":"PLoS ONE"},{"key":"95_CR22","first-page":"2562","volume":"37","author":"FY Ding","year":"2011","unstructured":"Ding FY, Ma GF, Song XH, Shi WH, Lan JY, Yu HY. Relationship between cyp1a1 gene polymorphism and genetic susceptibility of cervical carcinoma. Jiangsu Med J. 2011;37:2562.","journal-title":"Jiangsu Med J"},{"key":"95_CR23","first-page":"762","volume":"35","author":"J Geng","year":"2010","unstructured":"Geng J, Shi YR, Wang H, Qin R. Research of cytochrome p450 i a1 lle\/val polymorphism and genetic susceptibility in cervical cancer. J Bengbu Med Coll. 2010;35:762.","journal-title":"J Bengbu Med Coll"},{"issue":"05","key":"95_CR24","first-page":"428","volume":"38","author":"YR Shi","year":"2011","unstructured":"Shi YR, Geng J, Cheng LQ, Wang H, Zhang Y. Association of cytochrome p450 1a1 gene polymorphisms with cervical cancer. Fudan Univ J Med Sci. 2011;38(05):428\u201331.","journal-title":"Fudan Univ J Med Sci"},{"key":"95_CR25","unstructured":"Zhang SH, Kong AR. Polymorphisms of cyp1a1 gene and hpv infection of cervical squamous carcinoma: Master\u2019s thesis of Taishan Medical University; 2009."},{"key":"95_CR26","first-page":"419","volume":"32","author":"X Zhang","year":"2011","unstructured":"Zhang X. P450 1a1 gene polymorphism and cervical cancer level correlation. Jilin Med J. 2011;32:419.","journal-title":"Jilin Med J"},{"issue":"4","key":"95_CR27","first-page":"267","volume":"18","author":"YK Huang","year":"2006","unstructured":"Huang YK, Hsieh HC, Sun JA, et al. Genetic polymorphisms of phase I and phase II xenobiotic enzymes in human papillomavirus related lesion and cancer of the uterine cervix. Tzu Chi Med J. 2006;18(4):267\u201374.","journal-title":"Tzu Chi Med J"},{"issue":"6","key":"95_CR28","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s13277-012-0488-y","volume":"33","author":"S Yang","year":"2012","unstructured":"Yang S, Jia C, Zhu H, et al. CYP1A1 Ile462Val polymorphism and cervical cancer: evidence from a meta-analysis. Tumour Biol. 2012;33(6):2265\u201372.","journal-title":"Tumour Biol"},{"issue":"6","key":"95_CR29","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.1007\/s11033-012-1470-x","volume":"39","author":"TN Sergentanis","year":"2012","unstructured":"Sergentanis TN, Economopoulos KP, Choussein S, et al. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: a meta-analysis. Mol Biol Rep. 2012;39(6):6647\u201354.","journal-title":"Mol Biol Rep"},{"issue":"48","key":"95_CR30","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1038\/sj.onc.1205807","volume":"21","author":"MJ Thun","year":"2002","unstructured":"Thun MJ, Henley SJ, Calle EE. Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene. 2002;21(48):7307\u201325.","journal-title":"Oncogene"},{"issue":"5","key":"95_CR31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00008571-199410000-00002","volume":"4","author":"MT Landi","year":"1994","unstructured":"Landi MT, Bertazzi PA, Shields PG, et al. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics. 1994;4(5):242\u20136.","journal-title":"Pharmacogenetics"},{"key":"95_CR32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/carcin\/18.3.503","volume":"18","author":"LA Mooney","year":"1997","unstructured":"Mooney LA, Bell DA, Santella RM, et al. Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis (Lond.). 1997;18:503\u20139.","journal-title":"Carcinogenesis (Lond.)"},{"key":"95_CR33","first-page":"3926","volume":"56","author":"ZY Zhang","year":"1996","unstructured":"Zhang ZY, Fasco MJ, Huang L, et al. Characterization of purified human recombinant cytochrome P4501A1-lle462 and Val462: assessment of a role for the rare allele in carcinogenesis. Cancer Res. 1996;56:3926\u201333.","journal-title":"Cancer Res"},{"key":"95_CR34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/bbrc.1997.6051","volume":"231","author":"I Persson","year":"1997","unstructured":"Persson I, Johansson I, Ingelman-Sundberg M. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem Biophys Res Commun. 1997;231:227\u201330.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9312","key":"95_CR35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","volume":"359","author":"N Mu\u00f1oz","year":"2002","unstructured":"Mu\u00f1oz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Multicentric Cervical Cancer Study Group. Lancet. 2002;359(9312):1093\u2013101.","journal-title":"Lancet"}],"container-title":["Molecular Diagnosis &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-014-0095-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-014-0095-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-014-0095-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T18:12:44Z","timestamp":1551204764000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-014-0095-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,14]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["95"],"URL":"https:\/\/doi.org\/10.1007\/s40291-014-0095-2","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,14]]}}}